Thomas B. Smith, M.D., has joined Kendle as Global Medical Director. In this role, Dr. Smith will provide medical and therapeutic expertise to Phase I-IV clinical development projects and proposals for the company’s biopharmaceutical customers, with an emphasis on projects in the Central Nervous System (CNS) therapeutic area. Dr. Smith brings to Kendle significant experience in CNS drug development, having led a clinical team in the preparation and submission of an IND for a novel compound for A...